Breast cancer and melatonin: Magnetic fields block melatonin’s oncostatic (anti-cancer) action

By Liburdy RP, Sloma TR, Sokolic R, Yaswen P Department of Cell and Molecular Biology, Life Science Division, Lawrence Berkley Laboratory, US Berkley, CA 9472 “These results provide the first evidence that ELF frequency magnetic fields can act at the cellular levels to enhance breast cancer cell proliferation by blocking melatonin’s natural oncostatic action. In addition, there appears to be a dose threshold between 2 and 12 mG.” View at PubMed: http://www.ncbi.nlm.nih.gov/pubmed/8320637